Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (DRKS00041542) titled 'Evaluation of 45S5-bioactive glass in total hip arthroplasty in patients with protrusio acetabuli and coxa profunda: a post market non interventional prospective study' on Sept. 7.
Study Type: observational
Study Design:
Allocation:
Masking:
Control:
Assignment:
Study design purpose: treatment
Primary Sponsor: NORAKER the bioglass company
Condition:
M16.1
Other primary coxarthrosis
Intervention:
Group 1: Eligible patients are identified during the eligibility consultation, and their willingness to participate in the study is assessed. There are no disadvantages to not participating, nor does the treatment pla...